medisourceasia.com

Industry News


Home

About 
medisourceasia

Magazine
Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info

Contact

 

Planning Commission For Hiking Health Expenditure To 2.5% of GDP By End Of Next Five Year Plan

With health getting less share in the original allocation for the11th Five Year Plan period and the utilisation again falling way below the target, the Planning Commission now wants to increase the allocation for health during next Plan period.

The expenditure on health by Centre and the States should increase from the current 1.3 per cent of the GDP to at least 2 per cent and perhaps 2.5 per cent by the end of the 12th Plan period, according to the initial notes prepared by the Planning Commission about the tones and quantum of the next Plan.

There is a desperate shortage of medical personnel and there is need for targeted approach to nursing colleges and other licensed increase seats in medical colleges. The quality of National Rural Health Mission should be improved according to the NRHM infrastructure. The role of public-private partnership in secondary and tertiary healthcare must be expanded. Health insurance cover should be expanded to all disadvantaged groups. Focus must be on women and children and the ICDS needs to be revamped, according to the initial assessment of the Panel.

The Panel has found that the current utilisation during the ongoing period was also below the target. Out of the total allocation of Rs.123,901 crore for the 11th Plan, only 61 per cent was used so far. At the start of the current FYP the expenditure on health was below 1 per cent of the GDP, but it has picked up to 1.1 per cent during 2009-10, as per the mid-term appraisal. As per the latest estimates, it is at 1.3 per cent of the GDP, but still much lower to the target of 2 per cent by the end of 2012, sources said.

The public discussions initiated by the Panel also attracted suggestions from the public that the quality of public healthcare systems was below the desired levels. Panel has prepared the concept note and taking inputs from the public through different platforms including social networking sites before finalising the directions of the next Plan.

(Ref: http://www.pharmabiz.com/NewsDetails.aspx?aid=62955&sid=1)
 


Industry To Move Court Against Introduction Of Bar Coding For Exports

With the union commerce ministry standing firm on its decision to make bar coding mandatory for all pharma exports from July 1 this year to check the export of spurious (fake) drugs from the country, the pharma industry is bracing up itself to move court against the introduction of bar coding in the country which, the industry said, is alarming as a section of the exporters may lose the entire export business in one stroke of the ministry.

Sources in the industry said that just on the lines of FDC and CoPP issues, some of the affected parties are preparing to move court. A detailed petition to contest the government's decision in this regard is in the drafting stage and the industry may move high court in two or three days time if the ministry does not make any amendments in its decision which the industry contests is a 'fake solution to a fake problem.

Contesting the government's plea that the bar coding is being implemented in the country to check spurious (fake) drugs, the industry said that the bar code technology is not fool proof. It is possible for counterfeits to copy, create and use bar codes. If ATM cards can be duplicated, so can bar codes. Spurious drugs can also have bar codes, the industry leaders said.

Industry leaders say that the implementation of bar code as per GS1 global standards is cumbersome, time-consuming and costly. And what has raised concerns for the SMEs is the provision seeking the introduction of the bar code at three levels, instead of just the primary packages. Industry leaders pointed out that for small companies, who will not have huge quantum of export, the bar coding will be a huge burden as the specified machines for the same can cost up to Rs.40 lakhs.

Industry leaders also point out that if the item number 3 of the notification is implemented, it will have a far reaching effect in the exports and there will be lot of delay in manufacturing the products and to follow the procedures which is tedious and time consuming. The item number 3 of the ministry's notification mentions that the exporter of pharmaceutical products will build track and trace capability for their exported medicines using barcode technology as per GS1 global standards. The same will need to be done at primary, secondary and tertiary level packaging labels.

(Ref: http://www.pharmabiz.com/NewsDetails.aspx?aid=63185&sid=1)

Other News

Plumat acquires Colpitt BV
Foster Builds Medical Plastics Innovation Center
Plastics in Medical Devices event returns to Northeast Ohio
Value of Indian medical devices market to touch US$ 6.41 bn by 2014

Archives

Advertisement

 

Back | Back To Top | Previous | Next